CardioMEMS

Abbott's implantable cardiac monitor CardioMEMS lands expanded FDA designation
By Laura Lovett | 01:19 pm | February 21, 2022
The system first landed clearance in 2014 for Class III heart failure patients. 
St. Jude receives FDA 510(k) clearance for mobile-enabled spinal cord stimulation trial system
By Aditi Pai | 10:06 am | July 16, 2015
CardioMEMS gets FDA clearance for implanted artery pressure sensor, St. Jude to acquire it
By Aditi Pai | 09:59 am | May 29, 2014
FDA panel rejects CardioMEMS wireless, implantable heart monitor
By Neil Versel | 06:18 am | December 13, 2011
St. Jude may acquire CardioMEMS for $375M
By Brian Dolan | 10:02 am | September 08, 2010
Only 4% move medical device data to mobiles
By Brian Dolan | 11:49 am | August 04, 2010
CardioMEMS: 38% fewer heart failure hospitalizations
By Brian Dolan | 04:01 pm | June 02, 2010
Heart failure sensor startup gets $37.9M investment
By Brian Dolan | 08:00 am | May 10, 2010
The 15 wireless health VC deals of 2009
By Brian Dolan | 05:52 am | December 29, 2009
Uptick in investments in medtech start-ups
By Brian Dolan | 08:51 am | September 04, 2009